OVERVIEW
DEPRESSION- CURRENT THERAPY AND WHAT WE CAN EXPECT
DEPRESSION - REDUCTION OF PRACTICE VARIABILITY - PCP VS. SPECIALIST
EPILEPSY : NO LONGER IN THE DARK AGES
FUTURE DIRECTIONS IN PAIN MANAGEMENT RESEARCH : TALK FROM THE FRONT LINE
MULTIPLE SCLEROSIS : BETTER DRUGS BUT NO CURE IN SIGHT
PAIN MARKET - IT'S LIKE THE EVEREADY BUNNY
PARKINSON's DISEASE : DEMOGRAPHICS DEMAND BETTER TREATMENTS
SCHIZOPHRENIA : LONG TERM THERAPY, BUT LESS THAN IDEAL RESULTS
SLEEP DISORDERS : NO FAILED ANTIHISTAMINES NEED APPLY